Beijing Zhongyan Tongrentang Pharmaceutical Research and Development

Beijing Zhongyan Tongrentang Pharmaceutical Research and Development is a specialized research entity focused on the modernization and scientific advancement of Traditional Chinese Medicine (TCM). Established as a joint venture between the historic Beijing Tongrentang Group and the China Academy of Chinese Medical Sciences, the company serves as a bridge between ancient herbal traditions and modern pharmaceutical standards. Its core activities include the formulation of new TCM drugs, the optimization of existing classic prescriptions, and the development of evidence-based health supplements. The company plays a critical role in the Tongrentang ecosystem by providing the scientific rigor and clinical validation necessary for its extensive portfolio of natural products. By integrating contemporary pharmacological techniques with traditional knowledge, it aims to improve the quality and efficacy of TCM therapies for chronic conditions.